Avacta Group (AVCT) Competitors GBX 57.70 +2.90 (+5.29%) As of 09/5/2025 11:41 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock AVCT vs. ERGO, OXB, SLN, PRTC, HZD, FARN, VRP, ARIX, CIR, and BVXPShould you be buying Avacta Group stock or one of its competitors? The main competitors of Avacta Group include Ergomed (ERGO), Oxford Biomedica (OXB), Silence Therapeutics (SLN), PureTech Health (PRTC), Horizon Discovery Group plc (HZD.L) (HZD), Faron Pharmaceuticals Oy (FARN), Verona Pharma plc (VRP.L) (VRP), Arix Bioscience (ARIX), Circassia Group (CIR), and Bioventix (BVXP). These companies are all part of the "biotechnology" industry. Avacta Group vs. Its Competitors Ergomed Oxford Biomedica Silence Therapeutics PureTech Health Horizon Discovery Group plc (HZD.L) Faron Pharmaceuticals Oy Verona Pharma plc (VRP.L) Arix Bioscience Circassia Group Bioventix Avacta Group (LON:AVCT) and Ergomed (LON:ERGO) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, media sentiment, earnings, profitability, risk and dividends. Which has higher valuation & earnings, AVCT or ERGO? Ergomed has higher revenue and earnings than Avacta Group. Avacta Group is trading at a lower price-to-earnings ratio than Ergomed, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAvacta Group£113K2,051.50-£30.08M-£0.15-376.14Ergomed£152.09M0.00£15M£0.29N/A Which has more risk & volatility, AVCT or ERGO? Avacta Group has a beta of 1.12, suggesting that its share price is 12% more volatile than the S&P 500. Comparatively, Ergomed has a beta of 0.79, suggesting that its share price is 21% less volatile than the S&P 500. Is AVCT or ERGO more profitable? Ergomed has a net margin of 9.87% compared to Avacta Group's net margin of -114.45%. Ergomed's return on equity of 18.08% beat Avacta Group's return on equity.Company Net Margins Return on Equity Return on Assets Avacta Group-114.45% -74.00% -21.80% Ergomed 9.87%18.08%10.16% Do institutionals & insiders believe in AVCT or ERGO? 13.5% of Avacta Group shares are held by institutional investors. Comparatively, 71.1% of Ergomed shares are held by institutional investors. 54.5% of Avacta Group shares are held by company insiders. Comparatively, 18.2% of Ergomed shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the media favor AVCT or ERGO? In the previous week, Avacta Group had 1 more articles in the media than Ergomed. MarketBeat recorded 1 mentions for Avacta Group and 0 mentions for Ergomed. Avacta Group's average media sentiment score of 0.00 equaled Ergomed'saverage media sentiment score. Company Overall Sentiment Avacta Group Neutral Ergomed Neutral SummaryErgomed beats Avacta Group on 8 of the 11 factors compared between the two stocks. Get Avacta Group News Delivered to You Automatically Sign up to receive the latest news and ratings for AVCT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AVCT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AVCT vs. The Competition Export to ExcelMetricAvacta GroupBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£231.82M£237.89M£5.79B£2.56BDividend Yield3.97%3.78%6.70%5.30%P/E Ratio-376.1443.3476.285,361.54Price / Sales2,051.505,225.30557.4596,444.19Price / Cash15.0013.1925.7027.93Price / Book3.9287.2111.487.02Net Income-£30.08M-£90.99M£3.29B£5.89B7 Day Performance-5.10%0.83%1.11%0.27%1 Month Performance26.98%16.63%8.20%55.19%1 Year Performance-20.85%516.57%61.23%184.43% Avacta Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AVCTAvacta GroupN/AGBX 57.70+5.3%N/A-20.9%£231.82M£113K-376.14120News CoverageERGOErgomedN/AN/AN/AN/A£701.00M£152.09M4,641.386OXBOxford Biomedica1.0703 of 5 starsGBX 569+2.2%GBX 540.25-5.1%+78.5%£604.85M£98.31M-4.23891SLNSilence TherapeuticsN/AN/AN/AN/A£480.35M£11.35M-11.01100High Trading VolumePRTCPureTech HealthN/AGBX 125.20-6.6%GBX 455+263.4%-21.7%£376.08M£521.32K-5.14300HZDHorizon Discovery Group plc (HZD.L)N/AN/AN/AN/A£302.98M£54.63M-33.55416FARNFaron Pharmaceuticals OyN/AGBX 190-10.6%N/A-10.3%£255.08MN/A-5.0834Gap DownVRPVerona Pharma plc (VRP.L)N/AN/AN/AN/A£228MN/A-1.6822Gap UpARIXArix BioscienceN/AN/AN/AN/A£183.73M£14.16M1,290.919CIRCircassia GroupN/AN/AN/AN/A£142.66M£27.90M3,400.00111Gap DownBVXPBioventixN/AGBX 2,540+0.6%N/A-38.4%£133.00M£13.65M16.4312News Coverage Related Companies and Tools Related Companies Ergomed Alternatives Oxford Biomedica Alternatives Silence Therapeutics Alternatives PureTech Health Alternatives Horizon Discovery Group plc (HZD.L) Alternatives Faron Pharmaceuticals Oy Alternatives Verona Pharma plc (VRP.L) Alternatives Arix Bioscience Alternatives Circassia Group Alternatives Bioventix Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:AVCT) was last updated on 9/8/2025 by MarketBeat.com Staff From Our PartnersThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored6-Figure Target for BTC by 2025Trump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredWall Street Legend Names #1 ‘Hidden’ AI Stock50-year Wall Street legend says to forget NVDA. For the biggest potential gains, it's time to move your money ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avacta Group Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Avacta Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
